Hypertensive emergencies in children: Identification and management of dangerously high blood pressure

Minerva Pediatrica

Volumn 61, Issue 2, 2009, Pages 175-184

  Constantine, E ^a,b   Merritt, C ^a  

^a BROWN UNIVERSITY   (United States)

^b HASBRO CHILDREN'S HOSPITAL   (United States)

Author keywords

Antihypertensive agents; Hypertension, diagnosis; Hypertension, therapy

Indexed keywords

CLEVIDIPINE; ENALAPRILAT; ESMOLOL; FENOLDOPAM; HYDRALAZINE; LABETALOL; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; PHENTOLAMINE;

BLOOD PRESSURE MEASUREMENT; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONTINUOUS INFUSION; DIFFERENTIAL DIAGNOSIS; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; FLUSHING; HEADACHE; HEART BLOCK; HUMAN; HYPERTENSION; HYPOTENSION; INTRACRANIAL HYPERTENSION; INTRAOCULAR HYPERTENSION; LOADING DRUG DOSE; NAUSEA; PHLEBITIS; PREVALENCE; RECOMMENDED DRUG DOSE; REFLEX TACHYCARDIA; REVIEW; SIDE EFFECT; SYMPTOM; TACHYCARDIA;

EID: 67649519655     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Din-Dzietham R, Liu Y, Bielo MV, Shamsa F. High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation 2007;116:1488-96. (Pubitemid 47480640)
2. Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ. Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics 2004;113:475-482 (Pubitemid 38280786)
3. Puri M, Flynn JT, Garcia M, Nussbaum H, Freeman K, DiMartino-Nardi JR. The frequency of elevated blood pressure in obese minority youth. J Clin Hypertens (Greenwich) 2008;10:119-124
4. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents et al. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555-576
5. Linakis JL, Constantine E. Hypertension. In: Fleisher G, Ludwig S et al., editors. Textbook of pediatric emergency medicine 5th ed.: Lippincott Williams & Wilkins; 2006. p. 351-358
6. Varda NM, Gregoric A. A diagnostic approach for the child with hypertension. Pediatr Nephrol 2005;20:499-506. (Pubitemid 40392627)
7. Patel HP, Mitsnefes M. Advances in the pathogenesis and management of hypertensive crisis. Curr Opin Pediatr 2005;17:210-214 (Pubitemid 40516102)
8. Friedman AL. Approach to the treatment of hypertension in children. Heart Dis 2002;4:47-50. (Pubitemid 34601210)
9. Perez MI, Musini VM. Pharmacological interventions for hypertensive emergencies: a Cochrane systematic review. J Hum Hypertens 2008;22:596-607.
10. Baker-Smith CM, Benjamin DK Jr., Grabowski HG, Reid ED, Mangum B, Goldsmith JV et al. The economic returns of pediatric clinical trials of antihypertensive drugs. Am Heart J 2008;156:682-688
11. Permanand G, Mossialos E, McKee M. The EU's new paediatric medicines legislation: serving children's needs? Arch Dis Child 2007;92:808-811
12. Porto I. Hypertensive emergencies in children. J Pediatr Health Care;14:312-7; quiz 8-9.
13. Ishisaka DY, Yonan CD, Housel BF. Labetalol for treatment of hypertension in a child. Clin Pharm 1991;10:500-501
14. Flynn JT, Tullus K. Severe hypertension in children and adolescents: pathophysiology and treatment. Pediatr Nephrol 2008 [Epub ahead of print].
15. Tobias JD, Hersey S, Mencio GA, Green NE. Nicardipine for controlled hypotension during spinal surgery. J Pediatr Orthop;16:370-373 (Pubitemid 26123668)
16. Tenney F, Sakarcan A. Nicardipine is a safe and effective agent in pediatric hypertensive emergencies. Am J Kidney Dis 2000;35:E20.
17. Michael J, Groshong T, Tobias JD. Nicardipine for hypertensive emergencies in children with renal disease. Pediatr Nephrol 1998;12:40-42 (Pubitemid 28165779)
18. Flynn JT, Mottes TA, Brophy PD, Kershaw DB, Smoyer WE, Bunchman TE. Intravenous nicardipine for treatment of severe hypertension in children. J Pediatr 2001;139:38-43. (Pubitemid 32613985)
19. Sahney S. A review of calcium channel antagonists in the treatment of pediatric hypertension. Paediatr Drugs 2006;8:357-373 (Pubitemid 44912720)
20. Wiest DB, Garner SS, Uber WE, Sade RM. Esmolol for the management of pediatric hypertension after cardiac operations. J Thorac Cardiovasc Surg 1998;115:890-897 (Pubitemid 28196601)
21. Smerling A, Gersony WM. Esmolol for severe hypertension following repair of aortic coarctation. Crit Care Med 1990;18:1288-1290 (Pubitemid 20377785)
22. Egger DW, Deming DD, Hamada N, Perkin RM, Sahney S. Evaluation of the safety of short-acting nifedipine in children with hypertension. Pediatr Nephrol 2002;17:35-40. (Pubitemid 41490202)
23. Flynn JT. Safety of short-acting nifedipine in children with severe hypertension. Expert Opin Drug Saf 2003;2:133-139
24. Blaszak RT, Savage JA, Ellis EN. The use of short-acting nifedipine in pediatric patients with hypertension. J Pediatr 2001;139:34-37 (Pubitemid 32613984)
25. Murphy MB, Murray C, Shorten GD. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med 2001;345:1548-1557 (Pubitemid 33144922)
26. Strauser LM, Pruitt RD, Tobias JD. Initial experience with fenoldopam in children. Am J Ther 1999;6:283-288 (Pubitemid 29445369)
27. Hammer GB, Verghese ST, Drover DR, Yaster M, Tobin JR. Pharmacokinetics and pharmacodynamics of fenoldopam mesylate for blood pressure control in pediatric patients. BMC Anesthesiol 2008;8:6.
28. Rouine-Rapp K, Mello DM, Hanley FL, Mohan Reddy V, Soifer S. Effect of enalaprilat on postoperative hypertension after surgical repair of coarctation of the aorta. Pediatr Crit Care Med 2003;4:327-332
29. Pollack CV, Varon J, Garrison NA, Ebrahimi R, Dunbar L, Peacock WFt. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. Ann Emerg Med 2008 [Epub ahead of print].